Brian Huber

Suggest Changes
Learn More
INTRODUCTION New treatment options are needed for second-line therapy in patients with NSCLC. PATIENTS AND METHODS This was a phase Ib/II study in patients with nonsquamous NSCLC in whom 1 previous(More)
  • 1